申请人:Takeda Chemical Industries, Ltd.
公开号:EP0074599A1
公开(公告)日:1983-03-23
A compound of the general formula:
wherein R' is alkyl, cycloalkyl, cycloalkenyl, alkynyl, aryl. aralkyln, or a 5 to 8 membered heterocyclic group containing 1 to 4 hetero-atoms, each of the above members may be further substituted; and R2 is hydrogen or hydroxy-protecting group, or a pharmaceutically acceptable salt thereof, or an ester thereof is novel and possesses excellent antimicrobial activity and β-lactamass inhibitory activity, and is utillzable as a treatment agent for infections in man and mammals.
通式如下的化合物
其中 R'是烷基、环烷基、环烯基、炔基、芳基、芳烷基或含有 1 至 4 个杂原子的 5 至 8 个成员的杂环基团,上述每个成员可被进一步取代;R2 是氢或羟基保护基团,或其药学上可接受的盐,或其酯类是新颖的,具有优异的抗菌活性和β-内酰胺类抑制活性,可用作人类和哺乳动物感染的治疗剂。